Novo Nordisk to invest $4.1B in second fill-finish facility in Clayton, North Carolina

Novo Nordisk announced plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, North Carolina, adding 1.4 million square feet and 1,000 jobs. The facility will produce injectable treatments for obesity and chronic diseases.

“Novo Nordisk today announced plans to invest 4.1 billion US dollars to build a second fill and finishing manufacturing facility in Clayton, North Carolina, and grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases.”globenewswire.com

• 3 sources
• globenewswire.comNovo Nordisk announces 4.1 billion USD investment to expandNovo Nordisk A/SJun 24, 2024
• reuters.comWegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing | ReutersIsabelle Carlsson, Maggie FickJun 24, 2024
• digital.enr.comENR • July 15, 2024 • Expanding Pharmaceutical ProductionJames LeggateJul 13, 2024

Summarized from public sources; check the original articles before acting on it.